Application 203729
- Type
- ANDA
- Sponsor
- AMNEAL PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | QUININE SULFATE | QUININE SULFATE | CAPSULE;ORAL | 324MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 65162-811 | Quinine Sulfate | Quinine | Amneal Pharmaceuticals of New York, LLC | ANDA | Current |
| 65162-811 | Quinine Sulfate | Quinine | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-811 | Quinine Sulfate | Quinine | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-811 | Quinine Sulfate | Quinine | Amneal Pharmaceuticals LLC | ANDA | Current |